Correlation Between Ikena Oncology and Affimed NV
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Affimed NV, you can compare the effects of market volatilities on Ikena Oncology and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Affimed NV.
Diversification Opportunities for Ikena Oncology and Affimed NV
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ikena and Affimed is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Affimed NV go up and down completely randomly.
Pair Corralation between Ikena Oncology and Affimed NV
Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.25 times more return on investment than Affimed NV. However, Ikena Oncology is 3.93 times less risky than Affimed NV. It trades about -0.04 of its potential returns per unit of risk. Affimed NV is currently generating about -0.06 per unit of risk. If you would invest 173.00 in Ikena Oncology on August 30, 2024 and sell it today you would lose (4.00) from holding Ikena Oncology or give up 2.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. Affimed NV
Performance |
| Timeline |
| Ikena Oncology |
| Affimed NV |
Ikena Oncology and Affimed NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Affimed NV
The main advantage of trading using opposite Ikena Oncology and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
| Affimed NV vs. Ikena Oncology | Affimed NV vs. Eliem Therapeutics | Affimed NV vs. HCW Biologics | Affimed NV vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |